Legend Biotech (LEGN) Profit After Tax Growth (1y) (2020 - 2026)
Legend Biotech (LEGN) Profit After Tax Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 0.26% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 17,802.13% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 59.59% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -107.76% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 101.22% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Legend Biotech | 7.11 Bn | 6.46 Bn | 129.70 Mn | 46.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46.24% |
| Dec 31, 2025 | 17.05% |
| Sep 30, 2025 | 68.33% |
| Jun 30, 2025 | -589.05% |
| Mar 31, 2025 | -110.45% |
| Dec 31, 2024 | 18,329.78% |
| Sep 30, 2024 | -101.46% |
| Jun 30, 2024 | 90.86% |
| Mar 31, 2024 | 57.19% |
| Dec 31, 2023 | 99.89% |
| Sep 30, 2023 | 26.78% |
| Jun 30, 2023 | -3.22% |
| Mar 31, 2023 | -250.72% |
| Dec 31, 2022 | -60.38% |
| Sep 30, 2022 | 31.90% |
| Jun 30, 2022 | -11.91% |
| Mar 31, 2022 | -32,288.91% |
| Dec 31, 2021 | -46.87% |
| Sep 30, 2021 | -84.65% |
| Jun 30, 2021 | -27.81% |